Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

CD2_BENIGN_LIPO_SKIN_NOS

brain neoplasm: A neoplasm (disease) that involves the brain.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D17.3& Cause of death: ICD-10 — D17.3& 2 out of 7 registries used, show all original rules.	260
4. Check minimum number of events None	260
5. Include endpoints None	260
6. Filter based on genotype QC (FinnGen only)	260

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D17
Name in latin: Neoplasma benignum lipomatosum cutis sive textus subcutanei locis aliis sive non specificatis

NAME	CD2_BENIGN_LIPO_SKIN_NOS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D173
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D173
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1781	992	781
Only index persons	1694	957	737
Unadjusted period prevalence (%)
Whole population	0.03	0.03	0.02
Only index persons	0.03	0.04	0.03
Median age at first event (years)
Whole population	52.02	53.10	50.59
Only index persons	51.49	52.86	49.72

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	260	161	99
Unadjusted period prevalence (%)	0.05	0.05	0.04
Median age at first event (years)	52.82	50.98	55.81

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
230: Matched controls
2300

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D17.3

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

+∞

323.0

229

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

13.7

38.4

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

15.7

21.3

D17.9

ICD-10 Finland

Benign lipomatous neoplasm, unspecified

28.2

17.3

D17.2

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

15.3

15.9

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

49.4

12.0

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

8.7

10.9

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

9.8

10.2

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

7.6

8.4

D17.0

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

9.9

7.4

Z71.8

ICD-10 Finland

Other specified counselling

2.5

7.3

312

S04

ICPC

Lump/swelling localized

3.7

7.1

TQW99

NOMESCO Finland

Other minor procedure on skin

4.3

6.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023103) Potassium [Moles/volume] in Serum or Plasma

251

2228

4.65

7.52

15.0

15.7

3.9

4.0

mmol/l

1.34

244

2167

(40768804) Tissue Pathology biopsy report

131

897

1.93

6.29

2.3

2.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

250

2222

4.25

5.60

14.7

15.6

139.7

mmol/l

0.04

243

2162

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

234

2009

2.65

5.54

4.9

4.7

1.8

2.5

mu/l

0.61

220

1838

(3002256) Pathology report gross observation

285

2.13

5.30

1.5

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

236

2050

2.64

5.16

14.0

12.9

81.2

80.5

ml/min/173m2

0.18

205

1688

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

242

2165

2.70

4.27

14.2

13.5

25.0

22.3

mg/l

0.53

185

1679

(3013139) Helicobacter pylori Ag [Presence] in Stool

143

2.33

4.19

1.1

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

3.65

4.10

1.2

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

3.65

4.10

1.2

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

225

1968

2.06

3.96

17.0

14.7

40.7

40.3

0.53

181

1442

(3018010) Neutrophils/100 leukocytes in Blood

133

1009

1.65

3.86

6.0

5.2

56.2

57.5

0.60

122

942

(3002030) Lymphocytes/100 leukocytes in Blood

134

1022

1.64

3.78

6.1

5.4

28.1

27.3

0.39

122

948

(3044889) 12 lead EKG panel

187

1566

1.69

3.54

3.2

3.8

—

(3013115) Eosinophils [#/volume] in Blood

141

1101

1.61

3.53

6.3

5.6

0.2

e9/l

0.35

126

964

(3051651) Icteric interference index of Serum or Plasma

6.31

3.53

3.9

3.1

—

(3022096) Basophils/100 leukocytes in Blood

126

958

1.61

3.52

6.2

5.3

0.7

0.21

114

886

(3024561) Albumin [Mass/volume] in Serum or Plasma

122

922

1.61

3.48

4.3

4.5

36.4

35.8

g/l

0.62

113

866

(40768797) Stomach Pathology biopsy report

313

1.83

3.45

1.2

—

(3006504) Eosinophils/100 leukocytes in Blood

129

991

1.60

3.42

6.1

5.3

3.2

2.8

0.96

117

914

(3051611) Lipemic interference index of Serum or Plasma

5.14

3.40

3.8

2.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

250

2313

3.10

3.36

10.9

10.3

24.9

25.7

u/l

0.33

241

2238

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

113

845

1.60

3.34

2.2

1.9

98.0

95.4

pmol/l

0.22

422

(3019198) Lymphocytes [#/volume] in Blood

139

1093

1.58

3.30

6.1

5.3

1.9

2.0

e9/l

0.34

124

964

(1002224) Polysomnography panel

2.39

3.30

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

248

1.88

3.25

2.8

2.3

56.8

132.9

ug/g

2.49

199

(3022217) INR in Platelet poor plasma by Coagulation assay

256

1.87

3.24

22.2

18.2

1.7

1.3

inr

—

(3037467) Urinalysis macro (dipstick) panel - Urine

177

1477

1.62

3.24

4.2

4.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

227

2034

1.91

3.09

5.6

5.8

39.1

39.9

mmol/mol

0.78

216

1898

(3013650) Neutrophils [#/volume] in Blood by Automated count

154

1257

1.55

2.99

9.5

9.3

3.9

4.1

e9/l

0.70

132

1081

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

237

2163

2.08

2.93

4.1

4.5

4.7

mmol/l

0.16

223

2007

(3019069) Monocytes/100 leukocytes in Blood

127

998

1.53

2.90

6.3

5.6

8.6

0.04

116

932

(3006315) Basophils [#/volume] in Blood

134

1068

1.53

2.85

6.1

5.3

0.0

e9/l

0.66

117

918

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

111

856

1.52

2.72

2.5

2.3

78.6

77.2

nmol/l

0.20

100

765

(3014765) Yersinia sp identified in Stool by Organism specific culture

2.42

2.71

1.2

—

(3018095) Leukocytes [#/volume] in Urine

101

764

1.53

2.71

3.6

3.5

88.6

60.2

e6/l

0.34

543

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

239

2201

2.06

2.66

5.0

2.8

mmol/l

0.19

225

2031

(42529406) Shigella sp [Presence] in Stool by Culture

2.39

2.64

1.2

—

(40758558) Short blood count panel - Blood

561

1.56

2.61

9.5

7.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

459

1.59

2.55

1.4

1.7

1.4

1.1

mg/l

0.35

369

(3001604) Monocytes [#/volume] in Blood

132

1066

1.48

2.54

6.2

5.3

0.6

e9/l

0.00

115

914

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

192

1684

1.54

2.39

3.8

3.9

14.6

14.8

pmol/l

0.29

182

1526

(3031040) Bacteria [#/volume] in Urine by Automated count

165

1404

1.48

2.37

4.3

4.2

—

26.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2.30

2.33

1.3

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

408

1.58

2.32

3.7

3.0

2.5

mmol/l

1.13

362

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

193

1702

1.52

2.27

7.8

7.4

78.2

78.1

u/l

0.01

178

1594

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

168

1456

1.43

2.04

2.7

3.0

43.6

50.2

u/l

0.45

159

1367

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2.57

2.04

1.3

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

654

1.45

2.00

2.5

2.2

—

(4146454)

3.81

1.94

1.7

3.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

159

1.78

1.94

3.3

3.6

81.3

80.0

ng/l

0.03

144

(42870588) Differential panel, method unspecified - Blood

703

1.43

1.94

6.6

5.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

3.59

1.85

1.3

1.1

—

(3021589) Normoblasts [#/volume] in Blood

118

977

1.38

1.79

8.0

9.1

0.0

e9/l

0.58

804

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

269

1.58

1.77

3.6

2.8

9.1

8.1

umol/l

0.10

239

(40761535) Cells panel - Urine sediment

180

0.43

1.76

1.5

3.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

141

1.77

1.75

1.3

—

44.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

125

1050

1.37

1.71

6.0

6.6

1.2

mmol/l

0.02

109

886

(40761511) CBC panel - Blood by Automated count

241

2278

1.79

1.68

10.8

12.7

—

(3044941) Cell count panel - Synovial fluid

2.85

1.66

1.0

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

152

1.71

1.63

1.5

3.2

127.4

177.8

ng/l

0.61

135

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.62

1.62

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

230

2153

1.59

1.61

4.2

4.4

1.5

mmol/l

0.20

216

1983

(3004716) Salmonella sp identified in Stool by Organism specific culture

122

1.78

1.60

1.4

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

753

1.37

1.58

4.2

3.3

2.4

mmol/l

2.12

666

(3052851) Hemolysis interference index of Serum or Plasma

2.09

1.57

3.5

3.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

228

2133

1.56

4.6

6.0

mmol/l

0.01

211

1955

(3019309) Folate [Moles/volume] in Red Blood Cells

400

1.44

1.53

1.6

1.7

881.5

1213.8

nmol/l

2.13

299

(3014148) Varicella zoster virus Ab [Titer] in Serum

3.38

1.53

1.2

1.1

—

(4027681)

3.38

1.53

1.4

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

374

1.45

1.52

3.3

3.0

0.6

0.7

ug/l

1.17

247

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.42

1.47

1.6

1.9

—

(3025130) Human papilloma virus identified in Specimen

2.54

1.46

1.1

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

506

1.38

1.39

4.2

22.0

21.4

0.09

237

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

480

1.38

1.37

2.2

—

(36304419) Bacteria [Presence] in Urine

599

1.35

1.37

3.1

2.9

—

(3030467) Casts [#/volume] in Urine by Automated count

618

1.35

1.36

3.1

2.9

0.3

0.4

e6/l

0.37

457

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

357

1.42

1.33

3.1

2.6

0.6

1.0

e6/l

0.82

191

(4010399)

162

1.60

1.31

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

114

973

1.31

3.1

4.0

—

(3022145) Colonoscopy Study observation

255

1.48

1.29

1.4

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2.08

1.28

1.2

—

(3019150) Specific gravity of Urine by Refractometry

481

0.69

1.27

2.4

3.7

1.0

kg/l

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

140

1232

1.30

1.26

4.2

4.6

6.7

mmol/l

0.11

126

1144

(3021788) Differential panel - Synovial fluid

2.43

1.25

1.0

1.5

—

(3000494) Fungus identified in Specimen by Culture

266

1.46

1.23

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

329

1.41

1.19

3.2

2.8

3.1

2.4

e6/l

0.16

163

(40768443) Skin Pathology biopsy report

1.77

1.18

1.1

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

1.17

0.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

2.53

1.15

1.6

2.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

774

1.29

1.15

3.0

3.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

495

1.33

1.13

2.2

2.0

2.6

3.1

mg/l

0.82

422

(3018418) pH of Serum or Plasma

682

1.30

1.12

4.6

3.7

7.4

0.17

124

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.73

1.10

1.7

2.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

2.41

1.09

1.6

1.3

173.8

242.0

pmol/l

—

(3002582) Erythrocytes [#/volume] in Urine

666

1.29

1.08

3.3

3.0

37.7

136.2

e6/l

0.49

506

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1.96

1.07

2.3

0.3

0.4

u/ml

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

112

974

1.26

1.06

5.4

5.6

1.2

mmol/l

0.18

100

878

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

640

1.29

1.05

5.3

4.9

1.6

2.5

ug/l

1.15

574

(4035726)

206

1.46

1.04

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

271

0.64

1.03

6.1

7.4

—

(3029937) Albumin [Presence] in Urine by Test strip

603

0.75

1.01

3.0

3.7

0.0

estimate

0.00

211

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

220

2084

1.36

1.01

3.7

4.0

1.3

mmol/l

0.58

204

1907

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

2.20

0.98

1.0

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.98

0.0

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

4.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

488

1.30

0.96

2.3

3.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

363

1.32

0.91

1.6

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

126

0.54

0.91

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

136

1.51

0.89

1.9

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1.75

0.87

1.6

1.4

280.0

315.5

ug/g

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

854

0.80

0.87

3.3

3.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

412

1.30

0.86

2.7

3.6

1222.7

179.4

ng/l

0.42

317

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

332

1.32

0.83

1.2

1.9

—

(3009508) Creatinine [Moles/volume] in Urine

658

1.24

0.83

2.9

3.0

7.9

7.7

mmol/l

0.11

551

(3023511) Choriogonadotropin [Units/volume] in Urine

1.90

0.82

1.3

1.2

—

(3032080) INR in Blood by Coagulation assay

841

1.22

0.82

4.4

8.1

1.2

1.3

inr

0.11

265

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

106

1.54

0.81

3.3

9.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

235

1.36

0.80

1.3

1.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.79

0.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.79

0.0

4.0

—

(3003396) Base excess in Arterial blood by calculation

227

1.36

0.79

3.5

7.8

0.1

1.3

mmol/l

1.31

179

(3008401) Mugwort IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

184

1.40

0.77

2.4

2.8

78.0

70.9

e9/l

0.70

147

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.69

0.75

1.4

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.66

0.74

1.0

1.2

—

(1761868) Lipid panel - Serum or Plasma

809

0.82

0.73

2.8

2.9

—

(3027945) Reticulocytes/100 erythrocytes in Blood

248

1.33

0.73

2.7

2.8

1.9

1.8

0.42

221

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

135

1.44

0.71

1.9

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

105

939

1.20

0.71

2.8

2.6

96.0

125.7

ug/l

1.89

861

(40761536) Microorganisms panel - Urine sediment

192

0.66

0.71

2.9

3.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.94

0.71

1.4

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.57

0.70

1.6

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

232

1.33

0.70

1.3

1.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1.68

0.69

1.3

3.6

25.6

37.2

umol/l

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.80

0.66

6.4

3.3

59.6

74.2

u/ml

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

227

1.31

0.63

1.5

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.68

0.61

1.6

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

0.00

0.60

0.0

1.3

—

94.4

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

0.00

0.60

0.0

1.9

—

513.8

—

(3000492) Spirometry study

193

1.33

0.60

1.4

—

(3008295) Osmolality of Serum or Plasma

0.00

0.59

0.0

1.2

—

272.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

185

1.33

0.58

1.4

1.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

174

1643

1.18

0.58

3.6

4.0

10.3

11.8

mm/h

0.82

160

1508

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

146

1361

1.17

0.57

3.1

3.0

—

(3020891) Body temperature

0.57

7.2

4.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.68

0.57

1.2

1.6

—

(4034850)

0.55

0.57

9.0

10.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

232

1.28

0.55

1.7

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

1.59

0.54

1.0

1.1

—

(3000991) Gas panel - Venous blood

161

1.33

0.53

3.9

8.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.49

0.51

1.1

2.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1.49

0.51

1.3

—

3.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

156

0.69

0.51

2.6

4.1

4.4

kpa

0.20

151

(3023368) Bacteria identified in Blood by Culture

564

1.18

0.50

3.3

4.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

661

1.17

0.49

3.9

22.6

7.5

mg/mmol

0.44

421

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

119

1.37

0.49

1.2

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

191

1.28

0.48

2.3

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

115

1067

1.14

0.45

3.0

3.5

0.0

estimate

0.00

215

(3005322) IgE [Units/volume] in Serum or Plasma

139

1.32

0.45

1.2

99.3

330.0

u/ml

0.70

124

(3026493) Urate [Moles/volume] in Serum or Plasma

562

1.16

0.43

2.7

2.6

354.5

3897.5

umol/l

1.43

476

(46235355) HIV 1 and 2 tests - Meaningful Use set

325

0.81

0.43

1.7

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.45

0.42

1.1

1.3

—

(3045424) Erythrocytes [Presence] in Urine

1.52

0.41

1.4

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.37

0.41

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.41

0.0

1.1

—

(3016879) Cocaine [Presence] in Urine

1.34

0.40

1.1

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

240.6

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

552.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.40

0.0

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.40

0.0

3.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.40

0.0

1.1

—

35.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

0.00

0.39

0.0

3.1

—

56.0

—

(3000850) Epithelial cells [#/volume] in Urine

461

1.16

0.39

2.3

2.5

7.1

4.9

e6/l

0.43

406

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.40

0.38

1.0

1.2

—

(3026782) Osmolality of Urine

433

1.16

0.38

2.7

573.7

551.7

mosm/kgh2o

0.29

367

(3014576) Chloride [Moles/volume] in Serum or Plasma

263

1.20

0.38

4.7

6.8

105.5

104.1

mmol/l

0.83

255

(3011288) Drugs identified in Urine by Screen method

1.36

0.37

1.0

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1.36

0.37

1.0

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.36

0.37

2.0

—

(3042936) Bacteria identified in Isolate by Culture

298

0.82

0.37

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

368

1.17

0.36

1.5

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

117

1.30

0.36

1.1

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.38

0.35

1.9

1.7

—

(3018572) Chloride [Moles/volume] in Blood

1.34

0.34

3.3

6.9

105.3

104.9

mmol/l

—

(3039000) Anion gap in Blood

1.34

0.34

3.3

6.9

11.2

11.0

mmol/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.37

0.33

1.6

1.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1.34

0.32

2.5

4.8

0.9

0.15

(3021601) Nitrite [Presence] in Urine by Test strip

114

1077

1.10

0.31

4.5

4.6

0.0

estimate

0.00

216

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

100

0.69

0.31

1.7

2.3

1.2

—

100

(21494755) Public health laboratory ask at order entry panel

205

0.82

0.29

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

1.30

0.28

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

168

1.21

0.28

1.3

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.28

0.28

3.4

1.7

—

(3027008) Opiates [Presence] in Urine

1.26

0.27

1.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

1.26

0.27

1.1

1.2

—

(3027944) Amphetamines [Presence] in Urine

1.26

0.27

1.1

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

609

0.90

0.27

3.6

3.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

341

1.13

0.25

2.2

15.5

13.8

umol/l

0.74

313

(3019832) Treponema pallidum Ab [Presence] in Serum

142

1.21

0.25

1.4

1.7

—

(3012516) Albumin [Mass/volume] in Urine

624

1.10

0.24

3.3

3.2

193.9

251.2

mg/l

0.11

411

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

624

1.10

0.24

2.6

3.1

1408.4

1202.6

ng/l

0.14

530

(3009261) Glucose [Presence] in Urine by Test strip

114

1088

1.09

0.24

3.0

3.5

0.0

estimate

0.00

205

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1.25

0.23

1.4

2.3

1.7

1.6

g/l

0.36

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.29

0.23

1.0

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.26

0.23

6.0

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.26

0.23

6.0

1.7

3.2

3.7

g/l

—

(3007164) IgA [Mass/volume] in Serum or Plasma

448

0.90

0.21

1.3

2.3

2.4

g/l

0.17

258

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.19

0.21

1.0

1.4

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

0.00

0.21

0.0

1.4

—

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.21

0.0

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.21

0.0

15.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

0.00

0.21

0.0

1.4

—

68.8

—

(44813793)

0.00

0.21

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.21

0.0

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3012565) Volume of 24 hour Urine

0.00

0.21

0.0

2.7

—

2137.1

—

(3035880) pH of Pleural fluid

0.00

0.21

0.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.21

0.0

1.8

—

(3017732) Neutrophils [#/volume] in Blood

145

1.18

0.21

1.5

2.2

3.8

4.0

e9/l

0.13

113

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3017704) Immunofixation for Urine

0.00

0.21

0.0

1.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

136

1.19

0.20

1.2

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.26

0.20

1.0

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

14.1

—

2056.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

12.0

—

1166.2

—

(3015183) Erythrocyte sedimentation rate

0.00

0.20

0.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

0.00

0.20

0.0

1.2

—

422.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1.23

0.20

1.0

1.2

0.5

262.9

e6/l

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1.23

0.20

1.0

1.1

3.7

3.1

e6/l

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.20

0.20

1.3

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

290

1.12

0.19

2.1

2.3

26.9

23.0

0.59

251

(3021960) Folate [Moles/volume] in Serum or Plasma

504

1.09

0.19

1.6

1.5

17.2

21.4

nmol/l

1.96

419

(3013512) EKG study

627

0.92

0.18

3.5

3.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.17

0.18

1.3

1.1

—

(3047181) Lactate [Moles/volume] in Blood

1.15

0.17

3.4

6.7

1.1

1.2

mmol/l

—

(3019225) pH of Specimen

187

1.13

0.16

4.5

4.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.13

0.16

1.0

1.8

—

(3049717) Cytology report of Urine Cyto stain

0.78

0.16

1.5

2.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

234

0.89

0.15

1.4

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1.21

0.15

2.7

4.8

1.4

1.6

—

(3045414) Leukocytes [Presence] in Urine

0.80

0.15

1.9

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

817

1.06

0.14

2.8

3.6

16.9

27.8

ng/l

3.12

574

(3000330) Specific gravity of Urine by Test strip

100

0.79

0.14

7.1

3.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

273

0.91

0.13

1.5

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

117

0.85

0.13

1.4

1.7

—

(3019060) Gas panel - Arterial blood

136

0.88

0.11

4.1

4.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

136

0.88

0.11

1.0

1.7

1.6

1.5

g/l

0.11

124

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

248

0.92

0.10

5.2

4.5

31.1

32.2

0.25

162

(3004588) Protein electrophoresis panel - Serum or Plasma

145

0.89

0.09

5.0

2.4

—

(3026008) Bacteria identified in Urine by Culture

637

1.05

0.09

3.5

2.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

481

0.95

0.09

2.7

4.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

185

0.91

0.08

1.6

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.82

0.08

1.0

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

0.79

0.08

1.2

1.3

—

2.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.76

0.08

1.2

1.3

—

1.9

—

(4094501)

1.10

0.08

1.0

1.1

—

(3022313) Gas panel - Capillary blood

0.82

0.07

2.4

3.9

—

(3008898) HLA-B27 [Presence]

1.06

0.07

1.0

1.1

—

(3022621) pH of Urine by Test strip

132

0.90

0.07

3.6

2.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

395

0.96

0.06

1.3

10.7

31.1

iu/ml

—

132

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

178

1.07

0.06

1.3

2.4

7.7

ug/l

2.73

161

(3025941) Bacteria identified in Stool by Culture

121

1.08

0.04

1.4

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

191

1.05

0.03

4.3

8.6

125.5

120.1

g/l

0.78

184

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

370

0.97

0.03

1.2

1.3

1.5

7.7

u/ml

2.47

140

(3021447) Carbon dioxide [Partial pressure] in Venous blood

188

0.95

0.02

3.2

3.3

5.9

5.7

kpa

0.99

183

(3012544) pH of Venous blood

198

0.96

0.02

3.2

3.3

—

(3003694) ABO and Rh group [Type] in Blood

569

0.98

0.02

1.3

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

113

1.06

0.02

2.8

2.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

121

0.99

0.00

5.3

3.0

4.5

pmol/l

0.03

107

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

656

1.01

0.00

2.4

2.0

240.4

188.2

u/l

0.22

617

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

503

0.99

0.00

1.3

0.6

1.0

u/ml

1.16

139

(36660697) Celiac disease serology panel - Serum

183

0.98

0.00

1.3

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

114

0.96

0.00

2.1

3.8

2.0

mmol/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

214

0.98

0.00

2.6

3.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

703

0.99

0.00

1.7

2.4

52.8

57.1

u/l

0.59

653

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.0

2.4

—

(3003129) Base excess in Capillary blood by calculation

0.00

0.0

1.2

—

3.3

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.0

1.0

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.0

2.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

1.9

—

(3006576) Bicarbonate [Moles/volume] in Blood

0.00

0.0

5.2

—

25.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.00

0.0

4.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

0.0

1.0

—

10.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

0.00

0.0

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

0.0

1.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.84

0.00

9.4

4.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.00

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

0.00

0.0

1.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.0

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

18.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

0.0

1.8

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

38.7

—

(3020650) Glucose [Presence] in Urine

0.00

0.0

1.4

—

(4198724)

0.00

0.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.0

3.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(4211845)

0.00

0.0

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

0.0

5.5

—

44.1

—

(3011436) Histone Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

0.00

0.0

3.4

—

74.7

—

(3034426) Prothrombin time (PT)

0.00

0.0

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

0.92

0.00

2.7

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.7

—

105.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.0

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.1

—

(44806420)

0.00

0.0

2.6

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.0

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

0.00

0.0

1.0

—

68.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

2.4

—

113.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.91

0.00

1.6

1.8

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

0.0

1.0

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

0.0

2.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.97

0.00

2.5

2.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.6

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_LIPO_SKIN_NOS and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_LIPO_SKIN_NOS	0.961 [0.78, 1.19]	0.715
Birth year	0.994 [0.99, 1.0]	0.193

During the follow-up period (1.1.1998 — 31.12.2019), 112 out of 879 females with CD2_BENIGN_LIPO_SKIN_NOS died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_LIPO_SKIN_NOS	1.001 [0.81, 1.23]	0.993
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 103 out of 695 males with CD2_BENIGN_LIPO_SKIN_NOS died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_LIPO_SKIN_NOS.

N-year risk	Females	Males
1	0.086%	0.191%
5	0.541%	1.153%
10	1.358%	2.721%
15	2.642%	5.416%
20	4.742%	9.295%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LIPO_SKIN_NOS – Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints